Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells
IntroductionCarbamylation is a non-enzymatic post-translational protein modification common in patients with uremia that causes pro-atherogenic alterations in plasma proteins. It is abundantly present in late-stage atherosclerotic plaques; however, the pathogenic relevance and functional consequence...
Saved in:
| Main Authors: | Valeria Saar-Kovrov, Aleksandra Pawlowska, Adrien Guillot, Marion J. J. Gijbels, Judith C. Sluimer, Lieve Temmerman, Pieter Goossens, Barend M. E. Mees, Frank Tacke, Vera Jankowski, Joachim Jankowski, Marjo M. P. C. Donners, Erik A. L. Biessen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532250/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Protein carbamylation in atherosclerotic plaques correlates with uremia and disease progression, localizing predominantly to foam cells
by: Valeria Saar-Kovrov, et al.
Published: (2025-06-01) -
Bradykinin’s carbamylation as a mechanistic link to impaired wound healing in patients with kidney dysfunction
by: Marta Kaminska, et al.
Published: (2025-03-01) -
Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
by: Ashraf H Mohamed, et al.
Published: (2019-01-01) -
Proteomic analysis of infiltrating neutrophils from rheumatoid arthritis synovial fluid and their contribution to protein carbamylation
by: Xueting Chen, et al.
Published: (2025-04-01) -
METHOD OF FLUORIMETRIC DETERMINATION OF POTASSIUM CYANATE IN CARBAMYLATED DARBEPOIETIN ALPHA DRUG SUBSTANCE
by: A. D. Askretkov, et al.
Published: (2019-01-01)